PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9276494-10	1997	The N-methyl-D-aspartate-type receptor antagonist, dizocilpine, at 0.1-0.5 mg/kg i.p., produced a marked and persistent reduction in striatal glutamate decarboxylase 67 messenger RNA.	Dizocilpine Maleate	51-62	glutamate-ammonia ligase	Rattus norvegicus	142-165	
8547590-1	1995	Levels of mRNAs encoding for the two isoforms of glutamate decarboxylase, GAD67 and GAD65, were quantified in the rat striatum and cerebral cortex following single injections of the non-competitive NMDA receptor antagonist MK-801.	Dizocilpine Maleate	223-229	glutamate-ammonia ligase	Rattus norvegicus	49-72	
1680225-6	1991	Administration of dizocilpine at 1, 2, 3 or 5 h after injection of 100, 200 or 400 nmol quinolinate resulted in a similar temporal profile of neuroprotection, as assessed by measuring the activities of choline acetyltransferase and glutamate decarboxylase in striatal homogenates, which was independent of the degree of neurodegeneration produced by the different excitotoxin doses.	Dizocilpine Maleate	18-29	glutamate-ammonia ligase	Rattus norvegicus	232-255	
12373737-1	2002	This study examined the consequences of systemic treatment with either L-dopa or MK-801 on the levels of mRNAs encoding the 65 and 67 kDa isoforms of glutamate decarboxylase (GAD65 and GAD67) in the striatum and globus pallidus (GP) of rats rendered hemiparkinsonian by intranigral 6-hydroxydopamine injection.	Dizocilpine Maleate	81-87	glutamate-ammonia ligase	Rattus norvegicus	150-173